En Shu

881 total citations
62 papers, 646 citations indexed

About

En Shu is a scholar working on Pathology and Forensic Medicine, Rheumatology and Dermatology. According to data from OpenAlex, En Shu has authored 62 papers receiving a total of 646 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pathology and Forensic Medicine, 13 papers in Rheumatology and 11 papers in Dermatology. Recurrent topics in En Shu's work include Autoimmune Bullous Skin Diseases (10 papers), Urticaria and Related Conditions (7 papers) and Systemic Sclerosis and Related Diseases (7 papers). En Shu is often cited by papers focused on Autoimmune Bullous Skin Diseases (10 papers), Urticaria and Related Conditions (7 papers) and Systemic Sclerosis and Related Diseases (7 papers). En Shu collaborates with scholars based in Japan, Nigeria and United States. En Shu's co-authors include Obinna Onwujekwe, Mariko Seishima, Yasuo Kitajima, Iroka J. Udeinya, Yumi Aoyama, Yosuke Kanno, Yukari Yamamoto, Anthony Mbah, P. O. Okonkwo and Hiroyuki Kanoh and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Frontiers in Immunology.

In The Last Decade

En Shu

54 papers receiving 609 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
En Shu Japan 15 174 116 115 114 113 62 646
Byoung Kook Kim South Korea 20 178 1.0× 44 0.4× 103 0.9× 507 4.4× 79 0.7× 70 1.1k
Shahnaz Murad Malaysia 19 109 0.6× 369 3.2× 73 0.6× 170 1.5× 35 0.3× 49 1.1k
Arifa Nazneen Japan 14 210 1.2× 25 0.2× 77 0.7× 227 2.0× 33 0.3× 34 753
Tomomi Sato Japan 16 148 0.9× 67 0.6× 82 0.7× 190 1.7× 15 0.1× 58 946
Johannes Schulze Germany 17 58 0.3× 50 0.4× 67 0.6× 118 1.0× 37 0.3× 47 896
Mehmet Ali Gündoğdu Türkiye 12 34 0.2× 33 0.3× 104 0.9× 100 0.9× 56 0.5× 70 577
Simone D. Holligan Canada 9 144 0.8× 378 3.3× 35 0.3× 94 0.8× 59 0.5× 19 809
Gisèle Kanny France 20 121 0.7× 181 1.6× 122 1.1× 122 1.1× 299 2.6× 43 1.6k
Pascale Perrin France 18 44 0.3× 19 0.2× 100 0.9× 308 2.7× 187 1.7× 44 987
Arnaldo Capriles-Hulett Venezuela 21 159 0.9× 531 4.6× 27 0.2× 32 0.3× 167 1.5× 55 1.3k

Countries citing papers authored by En Shu

Since Specialization
Citations

This map shows the geographic impact of En Shu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by En Shu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites En Shu more than expected).

Fields of papers citing papers by En Shu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by En Shu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by En Shu. The network helps show where En Shu may publish in the future.

Co-authorship network of co-authors of En Shu

This figure shows the co-authorship network connecting the top 25 collaborators of En Shu. A scholar is included among the top collaborators of En Shu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with En Shu. En Shu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mizutani, Yoko, et al.. (2024). Diacron-Reactive Oxygen Metabolites Levels Are Initially Elevated in Patients with Bullous Pemphigoid. SHILAP Revista de lepidopterología. 4(4). 100282–100282. 1 indexed citations
2.
Mizutani, Yoko, En Shu, Hidenori Ohnishi, et al.. (2022). A case of VEXAS syndrome (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) with decreased oxidative stress levels after oral prednisone and tocilizumab treatment. Frontiers in Medicine. 9. 1046820–1046820. 14 indexed citations
3.
Matsuyama, Kanako, et al.. (2020). A Case of Dermatomyositis Coexisting with Both Anti-Mi-2 and Anti-NXP-2 Antibodies. Case Reports in Dermatology. 12(2). 92–97. 2 indexed citations
4.
Kanno, Yosuke, En Shu, Hiroyuki Kanoh, & Mariko Seishima. (2015). The Antifibrotic Effect of α2AP Neutralization in Systemic Sclerosis Dermal Fibroblasts and Mouse Models of Systemic Sclerosis. Journal of Investigative Dermatology. 136(4). 762–769. 15 indexed citations
5.
Shu, En, et al.. (2015). A Case of Felty’s Syndrome Associated with Skin Ulcers and Extranodal NK/T-cell Lymphoma. Acta Dermato Venereologica. 95(6). 754–755.
6.
Mizuno, Yuki, Go Kato, En Shu, et al.. (2015). Merkel Cell Polyomavirus-positive Merkel Cell Carcinoma in a Patient with Epidermodysplasia Verruciformis. Acta Dermato Venereologica. 95(1). 98–99. 5 indexed citations
7.
Fujisawa, Tomomi, En Shu, Hiroyuki Kanoh, et al.. (2015). Anti-SRP Antibody-positive Myopathy with Universal Alopecia and Multiple Vitiligo. Acta Dermato Venereologica. 95(4). 497–498.
8.
Kawase, K., et al.. (2014). Inflammatory Epidermolysis Bullosa Acquisita Effectively Treated with Minocycline. Acta Dermato Venereologica. 94(5). 615–616. 5 indexed citations
9.
Ukaejiofo, E. O., et al.. (2013). Subacute effects of methanolic crude leaf extract of Gnetum africanum on the haematological profile in albino Wistar rats. 3(2). 220–225.
10.
Shu, En, Miki Nagai, Hajime Nakano, et al.. (2011). Two cases of recessive dystrophic epidermolysis bullosa diagnosed as severe generalized. The Journal of Dermatology. 38(9). no–no. 1 indexed citations
11.
Shu, En, et al.. (2010). Drug Dosing in Adult and Paediatric Population in Developing Countries: Possible Pharmaceutical Misadventure (A Review). 1(2). 77–80. 1 indexed citations
12.
Yamamoto, Yukari, Yumi Aoyama, En Shu, et al.. (2007). Anti-desmoglein 3 (Dsg3) Monoclonal Antibodies Deplete Desmosomes of Dsg3 and Differ in Their Dsg3-depleting Activities Related to Pathogenicity. Journal of Biological Chemistry. 282(24). 17866–17876. 74 indexed citations
13.
Shu, En, et al.. (2005). Role of ascorbic acid in the prevention of iron-deficiency anaemia in pregnancy. Biomedical Research-tokyo. 16(1). 0. 8 indexed citations
14.
Shu, En, Hiroyuki Matsuno, Yosuke Kanno, et al.. (2005). αB-crystallin is phosphorylated during myocardial infarction: Involvement of platelet-derived growth factor-BB. Archives of Biochemistry and Biophysics. 438(2). 111–118. 19 indexed citations
15.
Onwujekwe, Obinna, et al.. (2005). Where do people from different socio–economic groups receive diagnosis and treatment for presumptive malaria, in south–eastern Nigeria?. Annals of Tropical Medicine and Parasitology. 99(5). 473–481. 34 indexed citations
16.
Shu, En, et al.. (2005). Adherence to Highly Active Antiretroviral Therapy (HAART): A Sel-reported Case Study from a Rural Area in Cameroon. Sahel Medical Journal. 7(4). 1 indexed citations
17.
Tanabe, Kumiko, Kouseki Hirade, Akira Ishisaki, et al.. (2004). Possible involvement of p44/p42 MAP kinase in retinoic acid-stimulated vascular endothelial growth factor release in aortic smooth muscle cells. Atherosclerosis. 175(2). 245–251. 8 indexed citations
18.
Shu, En, et al.. (2003). Should we really be promoting home or community -based malaria treatment? Insights from a study in Southeast Nigeria on the treatment of child -hood malaria. SHILAP Revista de lepidopterología. 6 indexed citations
20.
Shu, En, et al.. (1999). Influence of health education on community participation in rapid assessment of onchocerciasis prior to distribution of ivermectin.. PubMed. 76(6). 320–3. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026